“PhRMA Act” introduced in House

Pharmaceutical company CEOs would be required to annually attest that all evidence of serious adverse events for a drug has been disclosed to HHS under the Pharmaceutical Research & Manufacturers Accountability Act. Introduced by Reps. Pete Stark (D-Calif.) and Marion Berry (D-Ark.) on Feb. 16, the "PhRMA Act" (HR 870) would authorize jail time and fines for CEOs and other executives for "knowing concealment...of evidence of a serious adverse drug experience." The bill also would authorize imposition of fines if post-marketing studies are not completed in a specified time period...